GO:0004180 carboxypeptidase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004180 carboxypeptidase activity is a molecular_function defined as catalysis of the hydrolysis of a single C-terminal amino acid residue from a polypeptide chain.
• Carboxypeptidases are exopeptidases that trim the C-terminus of peptides and proteins, thereby controlling peptide hormone maturation, protein turnover, and tubulin detyrosination.
• Major enzyme families include metallocarboxypeptidases such as carboxypeptidase E (CPE), plasma carboxypeptidases CPB2 and CPN, lysosomal protective protein/cathepsin A (CTSA), and serine carboxypeptidases such as carboxypeptidase Y (CPY).
• Carboxypeptidase activity is implicated in neuroendocrine peptide processing, vascular leakage regulation, lysosomal storage disorders, and cancer-related tubulin modification.
• Loss or inhibition of carboxypeptidase activity can be studied with knockout, point-mutation, knock-in, and overexpression cell models, combined with activity assays and proteomics.
• CRISPR-based models allow causal testing of specific carboxypeptidase genes in peptide processing, lysosomal function, and cytoskeletal regulation.
Description
Carboxypeptidase activity (GO:0004180) is a molecular_function that removes a single amino acid from the C-terminus of a polypeptide chain. This exopeptidase activity is distinct from endopeptidase cleavage because it acts processively from the protein or peptide terminus, and it is essential for generating mature bioactive peptides, degrading proteins, and modifying tubulin. Researchers study carboxypeptidase activity because it sits at the intersection of neuroendocrine signaling, lysosomal catabolism, hemostasis, and cytoskeletal dynamics. The QuickGO definition states that GO:0004180 describes catalysis of the hydrolysis of a single C-terminal amino acid residue from a polypeptide chain. This precise definition matters because many downstream biological conclusions depend on distinguishing true carboxypeptidase activity from aminopeptidase or endopeptidase activities. In practice, carboxypeptidase activity is measured with synthetic peptide substrates, mass spectrometry, and activity-based assays, and it can be perturbed genetically with CRISPR knockout or point mutation.
carboxypeptidase activity At A Glance
| GO ID | GO:0004180 |
|---|---|
| GO term | carboxypeptidase activity |
| Ontology | molecular_function |
| Synonym | none |
| Definition | Catalysis of the hydrolysis of a single C-terminal amino acid residue from a polypeptide chain. |
| Major function | Removal of C-terminal amino acids from peptides and proteins, contributing to peptide maturation, protein degradation, and tubulin modification. |
| Representative enzymes | CPE, CPB2, CPN, CTSA, CPY, and S9-family acylaminoacyl peptidases. |
| Common assays | Synthetic peptide cleavage, mass spectrometry, and activity-based probes. |
| Disease relevance | Neuroendocrine disorders, galactosialidosis, vascular leakage, and cancer-related tubulin detyrosination. |
What Is GO:0004180?
In simple terms, carboxypeptidase activity means cutting one amino acid off the end of a protein or peptide chain. According to the QuickGO definition for GO:0004180, this activity catalyzes the hydrolysis of a single C-terminal amino acid residue from a polypeptide chain. The reaction is hydrolytic, meaning water is used to break the peptide bond at the C-terminus. This activity is classified as a molecular_function, so it describes what a protein does at the biochemical level rather than where it acts or which pathway it belongs to. Carboxypeptidases can be metalloenzymes, serine enzymes, or cysteine enzymes, and they often show specificity for particular C-terminal residues.
Why Is carboxypeptidase activity Important in Cell Biology?
Carboxypeptidase activity is important because it controls the final step in the maturation or degradation of many peptides and proteins, and small changes in this activity can alter hormone signaling, lysosomal function, vascular integrity, and cytoskeletal stability. Because GO:0004180 is a molecular_function, it provides a precise annotation target for interpreting enzyme assays and genetic perturbations, helping researchers avoid misclassifying aminopeptidase or endopeptidase effects.
• Controls the maturation of neuroendocrine peptides such as insulin and enkephalin through carboxypeptidase E.
• Regulates vascular leakage through plasma carboxypeptidases CPB2 and CPN.
• Contributes to lysosomal protein catabolism, with deficiency linked to galactosialidosis.
• Modifies tubulin by removing C-terminal tyrosine, a process inhibited by parthenolide.
• Is conserved across bacteria, fungi, and mammals, including streptococcal enzymes that convert angiotensin I to angiotensin II.
• Can be assayed with synthetic peptides and mass spectrometry to distinguish it from aminopeptidase activity.
• Provides a druggable or genetically tractable node for cancer, cardiovascular, and metabolic research.
• Is structurally adapted in S9 family enzymes for C-terminal peptide processing.
• Supports fungal physiology through carboxypeptidase Y activity and its large helical regulatory structure.
• Enables CRISPR-based causal tests of specific carboxypeptidase genes in cell models.
Molecular Mechanism of carboxypeptidase activity
Substrate recognition at the C-terminus
In simple terms: The enzyme must first grab the end of the protein chain.
Carboxypeptidases recognize the free C-terminal carboxyl group of a polypeptide substrate and position the terminal peptide bond in the active site. Structural studies of putative S9 acylaminoacyl peptidases from Bacillus subtilis reveal adaptations that support carboxypeptidase activity, including features that accommodate a C-terminal residue. This substrate recognition step determines whether a given enzyme can act on a peptide, and it distinguishes carboxypeptidases from aminopeptidases that act at the N-terminus.
Catalytic hydrolysis of the terminal peptide bond
In simple terms: Water is used to cut the last amino acid off the chain.
The catalytic mechanism of GO:0004180 involves hydrolysis of the peptide bond between the penultimate residue and the C-terminal residue. Different enzyme families use different catalytic strategies: metallocarboxypeptidases such as carboxypeptidase E depend on a zinc ion, whereas serine carboxypeptidases such as carboxypeptidase Y use a catalytic serine. In all cases, the reaction releases a free amino acid and a shortened polypeptide. The activity is processive in some enzymes, meaning multiple C-terminal residues can be removed sequentially.
Enzyme families and structural folds
In simple terms: Different carboxypeptidases are built from different protein shapes.
Carboxypeptidase activity is found in multiple structural families. The S9 family includes acylaminoacyl peptidases with structural adaptations for carboxypeptidase activity. Carboxypeptidase Y is a serine carboxypeptidase whose activity and maintenance are modulated by a large helical structure. Carboxypeptidase E is a metallocarboxypeptidase with a characteristic zinc-binding site. Plasma carboxypeptidases CPB2 and CPN are basic carboxypeptidases that regulate vascular leakage in mice. This structural diversity means that inhibitors and substrates must be validated for each enzyme family.
Cofactors and metal dependence
In simple terms: Some carboxypeptidases need a metal helper to work.
Many carboxypeptidases are metalloenzymes that require a divalent metal ion, typically zinc, for catalysis. The metal ion activates a water molecule for nucleophilic attack on the peptide bond. In contrast, serine carboxypeptidases such as carboxypeptidase Y use a catalytic triad and do not require a metal cofactor. This difference is important for experimental design because metal chelators can inhibit metallocarboxypeptidases but not serine carboxypeptidases.
Regulation and inhibition
In simple terms: Carboxypeptidase activity can be turned up, down, or blocked.
Carboxypeptidase activity is regulated at multiple levels, including gene expression, zymogen activation, pH, and endogenous inhibitors. The large helical structure of carboxypeptidase Y modulates its activity and maintenance. Pharmacological inhibition is possible: parthenolide inhibits tubulin carboxypeptidase activity, linking this activity to cytoskeletal regulation. DPP-4 can display carboxypeptidase activity on specific peptides, showing that substrate sequence influences activity. These regulatory layers make carboxypeptidases responsive to physiological and pharmacological inputs.
Key Genes Involved in GO:0004180 carboxypeptidase activity
The following genes and proteins represent major experimental models for studying carboxypeptidase activity (GO:0004180).
| Gene | Major Role | Research Relevance |
|---|---|---|
| CPE | Metallocarboxypeptidase that processes neuroendocrine peptides | Studied for peptide hormone maturation and neuroendocrine disease |
| CPB2 | Plasma basic carboxypeptidase | Regulates vascular leakage in mice |
| CPN1 | Plasma carboxypeptidase N subunit | Regulates vascular leakage with CPB2 |
| CTSA | Lysosomal protective protein/cathepsin A with carboxypeptidase activity | Deficiency linked to galactosialidosis |
| PRCP | Prolylcarboxypeptidase | Peptide processing and cardiovascular biology |
| CPM | Membrane-bound carboxypeptidase M | Peptide processing at cell surfaces |
| CPD | Carboxypeptidase D | Processing of peptides in secretory pathway |
| CPZ | Carboxypeptidase Z | Wnt signaling and extracellular matrix biology |
| CPA1 | Pancreatic carboxypeptidase A1 | Digestive enzyme and pancreatic disease models |
| CPA2 | Pancreatic carboxypeptidase A2 | Digestive enzyme and pancreatic disease models |
| CPB1 | Pancreatic carboxypeptidase B1 | Digestive enzyme and pancreatic disease models |
| CPY | Vacuolar serine carboxypeptidase Y in yeast | Model for enzyme structure and regulation |
| DPP4 | Dipeptidyl peptidase 4 with carboxypeptidase activity on some peptides | Peptide processing and diabetes research |
| S9 family peptidases | Bacterial acylaminoacyl peptidases with carboxypeptidase activity | Structural adaptation studies |
| Streptococcal carboxypeptidases | Viridans group streptococci enzymes that cleave angiotensin I | Homology to angiotensin-converting enzyme |
| Tubulin carboxypeptidase | Removes C-terminal tyrosine from tubulin | Cytoskeletal regulation and cancer |
How Is carboxypeptidase activity Regulated?
Carboxypeptidase activity is regulated by gene expression, proteolytic activation of zymogens, pH and ionic conditions, endogenous inhibitors, and structural elements within the enzyme. The large helical structure of carboxypeptidase Y modulates its activity and maintenance, showing that non-catalytic domains can control enzyme function. Plasma carboxypeptidases CPB2 and CPN are regulated in the circulation and act together to control vascular leakage in mice. Pharmacological inhibition by parthenolide demonstrates that tubulin carboxypeptidase activity can be blocked, which alters tubulin detyrosination. Substrate sequence also matters, as DPP-4 carboxypeptidase activity depends on the peptide context.
carboxypeptidase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CPE | Neuroendocrine peptide processing disorders | Knockout neuroendocrine cell line with peptide processing assays |
| CTSA | Galactosialidosis and lysosomal dysfunction | Patient-derived fibroblasts with lysosomal carboxypeptidase activity assays |
| CPB2 | Vascular leakage and hemostasis | Knockout mouse endothelial cells with permeability assays |
| CPN1 | Vascular leakage and hemostasis | Knockout mouse models with plasma carboxypeptidase assays |
| Tubulin carboxypeptidase | Cancer and microtubule dynamics | Cancer cell lines treated with parthenolide and tubulin detyrosination assays |
Neuroendocrine and peptide processing disorders
Carboxypeptidase E (CPE) is a key enzyme for processing neuroendocrine peptides, and its activity is required for generating mature hormones and neuropeptides. Dysregulation of CPE can therefore affect peptide hormone signaling. Because GO:0004180 describes the catalytic step, assays of CPE activity are used to link genotype to peptide processing phenotypes.
Lysosomal storage and galactosialidosis
Deficient lysosomal carboxypeptidase activity has been reported in galactosialidosis, a lysosomal storage disorder. This links GO:0004180 to lysosomal protein catabolism and suggests that measuring carboxypeptidase activity can help characterize lysosomal disease models.
Vascular leakage and hemostasis
Both plasma basic carboxypeptidases, carboxypeptidase B2 and carboxypeptidase N, regulate vascular leakage activity in mice. This places carboxypeptidase activity in the control of vascular barrier function and suggests that inhibitors or genetic models could be used to study edema and inflammation.
Cancer and cytoskeletal regulation
Parthenolide inhibits tubulin carboxypeptidase activity, which controls tubulin detyrosination and affects microtubule dynamics. Because microtubule dynamics are important in cancer, tubulin carboxypeptidase activity is a potential target for experimental cancer research.
From carboxypeptidase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CPE alter peptide hormone maturation? | CPE knockout neuroendocrine cell line |
| Does a point mutation in the catalytic site abolish carboxypeptidase activity? | Point-mutation knock-in of catalytic residues |
| Does lysosomal carboxypeptidase deficiency cause storage material accumulation? | CTSA knockout or patient fibroblasts |
| Does CPB2 or CPN loss change vascular leakage? | Knockout mouse endothelial cells |
| Can tagged carboxypeptidase be used to measure enzyme localization? | Tagged knock-in with fluorescent or affinity tag |
| Does overexpression of a carboxypeptidase increase substrate cleavage? | Overexpression cell line with peptide substrate assays |
How to Study the carboxypeptidase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Synthetic peptide activity assay | C-terminal cleavage of a peptide substrate | Measuring carboxypeptidase activity in cell lysates |
| Mass spectrometry | Exact mass of peptide products | Identifying C-terminal residue removal |
| Proteomics | Global changes in peptide or protein termini | Discovering endogenous substrates |
| Western blot | Protein expression and processing | Validating knockout or overexpression |
| Immunofluorescence | Subcellular localization and tubulin detyrosination | Studying cytoskeletal effects |
| Enzyme kinetics | Catalytic rate and substrate specificity | Comparing wild-type and mutant enzymes |
| Structural biology | Three-dimensional enzyme structure | Understanding catalytic adaptations |
| CRISPR screening | Gene requirements for carboxypeptidase activity | Identifying regulators in cells |
Enzymatic activity assays
Carboxypeptidase activity is commonly measured with synthetic peptide substrates that release a detectable product upon C-terminal cleavage. These assays can distinguish carboxypeptidase from aminopeptidase activity when appropriate substrates are used. Activity can also be monitored with mass spectrometry to identify the exact cleavage products.
Mass spectrometry and proteomics
Mass spectrometry can detect the removal of single C-terminal residues from peptides and proteins, providing direct evidence of GO:0004180 activity. Proteomics workflows can compare wild-type and mutant cells to identify endogenous substrates of specific carboxypeptidases.
Structural and biochemical analysis
Structural studies, such as those on S9 family acylaminoacyl peptidases, reveal how enzymes adapt to carboxypeptidase activity. Biochemical analysis of carboxypeptidase Y has shown that a large helical structure modulates activity and maintenance. These approaches help explain mechanism and guide inhibitor design.
Genetic perturbation and imaging
CRISPR knockout, point mutation, and knock-in models allow causal testing of specific carboxypeptidase genes. Fluorescent tagging can reveal subcellular localization, and imaging of tubulin detyrosination can report on tubulin carboxypeptidase activity. These methods link molecular_function to cellular phenotypes.
How CRISPR Can Be Used to Study GO:0004180 carboxypeptidase activity
Knockout
CRISPR knockout of a carboxypeptidase gene such as CPE, CTSA, CPB2, or CPN1 can abolish enzyme activity and reveal its contribution to peptide processing, lysosomal function, or vascular leakage. Knockout cell lines are useful for comparing activity assays between wild-type and null backgrounds.
Point Mutation
Point mutation of catalytic residues can separate carboxypeptidase activity from other functions of the same protein. For example, mutating the zinc-binding or catalytic residues of a metallocarboxypeptidase can test whether GO:0004180 activity is required for a phenotype. Point-mutation models are also useful for validating inhibitor specificity.
Knock-in
Knock-in of a tagged or reporter version of a carboxypeptidase allows localization and interaction studies while preserving endogenous regulation. Knock-in of disease-associated variants can test whether a mutation alters carboxypeptidase activity in a physiological context.
Overexpression
Overexpression of a carboxypeptidase can increase substrate cleavage and amplify phenotypes, making it easier to detect changes in peptide processing or tubulin modification. Overexpression models are also used to test whether a candidate enzyme is sufficient for a specific cleavage event.
How EDITGENE Supports carboxypeptidase activity Research
Researchers studying carboxypeptidase activity-related genes often need to determine whether a candidate gene is causally involved in peptide processing, lysosomal function, or cytoskeletal regulation. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses directly.
Contact EDITGENE today to design your custom CRISPR model for carboxypeptidase activity research.
Frequently Asked Questions About carboxypeptidase activity
What is carboxypeptidase activity?
Carboxypeptidase activity (GO:0004180) is the catalysis of the hydrolysis of a single C-terminal amino acid residue from a polypeptide chain.
What genes are involved in carboxypeptidase activity?
Key genes include CPE, CPB2, CPN1, CTSA, PRCP, CPM, CPD, CPZ, CPA1, CPA2, CPB1, and DPP4, among others.
What is the GO ID for carboxypeptidase activity?
The GO ID is GO:0004180.
Is carboxypeptidase activity a molecular function?
Yes, GO:0004180 is classified as a molecular_function in the Gene Ontology.
What diseases are linked to carboxypeptidase activity?
Links include neuroendocrine peptide processing disorders, galactosialidosis, vascular leakage, and cancer-related tubulin detyrosination.
How is carboxypeptidase activity measured?
It is measured with synthetic peptide substrates, mass spectrometry, and activity assays that detect C-terminal cleavage.
What is the difference between carboxypeptidase and aminopeptidase activity?
Carboxypeptidases remove C-terminal residues, while aminopeptidases remove N-terminal residues; DPP-4 can show both types of activity depending on the peptide.
Can carboxypeptidase activity be inhibited?
Yes, parthenolide inhibits tubulin carboxypeptidase activity, and other inhibitors target specific enzyme families.
What is carboxypeptidase E?
Carboxypeptidase E is a metallocarboxypeptidase that processes neuroendocrine peptides and is a major model for GO:0004180.
How do CRISPR models help study carboxypeptidase activity?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of specific carboxypeptidase genes and their substrates.
Conclusion
Carboxypeptidase activity (GO:0004180) is a fundamental molecular_function that trims C-terminal amino acids from peptides and proteins. It is carried out by diverse enzyme families and is important for neuroendocrine peptide processing, lysosomal catabolism, vascular leakage control, and tubulin modification. Because the activity can be measured biochemically and perturbed genetically, it is well suited for CRISPR-based causal studies. Researchers can use knockout, point-mutation, knock-in, and overexpression models to connect specific carboxypeptidase genes to cellular and disease phenotypes.
References
- 1. Chandravanshi K et al.. 2024. Structural adaptations for carboxypeptidase activity in putative S9 acylaminoacyl peptidase from Bacillus subtilis.. Int J Biol Macromol 282(Pt 1):136734 PMID: 39433196
- 2. Makino M et al.. 2019. Carboxypeptidase Y activity and maintenance is modulated by a large helical structure.. FEBS Open Bio 9(7):1337-1343 PMID: 31173671
- 3. Fricker LD. 1988. Carboxypeptidase E.. Annu Rev Physiol 50:309-21 PMID: 2897826
- 4. Tranchemontagne J et al.. 1990. Deficient lysosomal carboxypeptidase activity in galactosialidosis.. Biochem Biophys Res Commun 168(1):22-9 PMID: 2328002
- 5. Turalić A et al.. 2026. Aminopeptidase and carboxypeptidase activity of DPP-4 on the example of peptides LPQNIPPL and LPβ(3)hQNIPPL.. J Mol Graph Model 142:109173 PMID: 40957164
- 6. Fonrose X et al.. 2007. Parthenolide inhibits tubulin carboxypeptidase activity.. Cancer Res 67(7):3371-8 PMID: 17409447
- 7. Harty DWS et al.. 2011. Carboxypeptidase activity common to viridans group streptococci cleaves angiotensin I to angiotensin II: an activity homologous to angiotensin-converting enzyme (ACE).. Microbiology (Reading) 157(Pt 7):2143-2151 PMID: 21546583
- 8. Zhou Q et al.. 2022. Both plasma basic carboxypeptidases, carboxypeptidase B2 and carboxypeptidase N, regulate vascular leakage activity in mice.. J Thromb Haemost 20(1):238-244 PMID: 34626062
